We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

Blueprint Medicines (BPMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Stock analysts at Wedbush lowered their Q1 2025 earnings estimates for Blueprint Medicines in a research report issued on Wednesday ...

In the current U.S. market landscape, significant volatility has been observed as major indices like the Dow Jones and Nasdaq Composite experience sharp declines due to ongoing tariff concerns and ...

Blood-based proteomic profiling of 251 inflammatory proteins in 543 newly diagnosed patients with acute myeloid leukemia (AML) identified an eight-protein signature that enhances risk stratification.

Almost a year to the day after Roche pulled out a partnership on its underperforming cancer therapy Gavreto, Blueprint Medicines has sold US commercial rights to the drug to Rigel Pharma in a deal ...

During a live event, Xiuning Le, MD, PhD, discussed updated intracranial efficacy, overall survival, and safety of ...

The FDA has turned down Blueprint Medicines’ Ayvakit for more general use in gas­troin­testi­nal stro­mal tu­mour – a form of stomach cancer - after approving the drug in a narrower group ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

PTC Therapeutics, Inc. today announced that its executives will speak at the following conferences: Bank of America Securities ...

Because heat isn’t officially classified as a disaster, Delhi cannot draw from the State Disaster Response Fund (SDRF). Ironically, while the SDRF allocation in the Delhi 2025-26 Budget increased from ...